(Q39490668)

English

Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

based on heuristic

inferred from title

author name string

M W Steward

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

B M Sisley

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

C Stanley

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

S E Brown

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

C R Howard

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1988

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

19-25

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

describes a project that uses

synthetic peptide

1 reference

based on heuristic

inferred from title

Antigenicity of reduced and alkylated Australia antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A surrogate hepatitis B virus antigenic epitope represented by a synthetic peptide and an internal image antiidiotype antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preparation of hepatitis B polypeptide micelles from human carrier plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of preexisting antibody against hepatitis B surface antigen to prevent subsequent hepatitis B infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of the affinity of antibodies to hepatitis B surface antigen in human sera

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell-mediated immunity to hepatitis B surface antigen in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B virus contains pre-S gene-encoded domains

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell antigenic sites tend to be amphipathic structures

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of antiviral antibodies with predetermined specificity using synthetic peptide--beta-lactamase conjugates: application to antibodies specific for the preS region of the hepatitis B virus envelope proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of Hepatitis B Surface Antigen Components Solubilized with Triton X-100

1 reference

https://pubmed.ncbi.nlm.nih.gov/3349646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39490668&oldid=1878821076"